Investorideas.com

Call 800 665 0411 to learn about our services for your stock

Search   Follow Investorideas on Twitter   Investorideas is on Facebook   Investorideas is on Youtube   Investorideas is on Pinterest  Investorideas is on stocktwits   Investorideas is on tumblr   Investorideas is on LinkedIn   Investorideas Instagram   Investorideas Telegram   Investorideas Gettr   Investorideas RSS




Share on StockTwits

Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 457 (TSX: VLNS) (TSXV: MTRX) (CSE: TER) (TSXV: N) (TSXV: NDVA)

 

Delta, Kelowna, BC - August 20, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/082020-StocksToWatch.mp3

Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 457 (TSX: VLNS) (TSXV: MTRX) (CSE: TER) (TSXV: N) (TSXV: NDVA)

SHARE PODCAST:      

Hear Investor ideas cannabis potcast on iTunes

Hear the investor ideas potcast on Spotify

Today's podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today's podcast we look at a few public and private company announcements.

The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) announced that it has received its Cannabis Research Licence under Health Canada's Cannabis Act and Cannabis Regulations through its wholly-owned subsidiary, Valens Agritech Ltd.

This licence permits The Valens Company to conduct research involving the administration or distribution of cannabis to human subjects for the assessment of taste, sight, smell or touch, subject to conditions laid out by Health Canada. The Company will use this licence to conduct controlled human trials for the sensory evaluation of its cannabis extracts, concentrates and oils, including vaporizers, and beverage and edible products, at its extraction, manufacturing and testing facilities in Kelowna, B.C.

"This exciting and strategic milestone gives us the competitive advantage to further innovate and differentiate our leading oil-based product offerings," said Tyler Robson, Chief Executive Officer of The Valens Company. "With this research licence, we are now able to perform sensory assessments at the product development stage to determine quality and marketability of our products to maximize potential launch success. Findings from future proprietary research initiatives will advance our understanding of cannabis preferences allowing us to continue developing premium, next generation products that meet evolving customer and consumer needs."

Sensory evaluation measures, analyses, and interprets the reactions of human subjects to products as perceived by the senses, and is used as a way of determining whether product differences are detected, the basis for those differences and the diversity of preferences. This evaluation method will enhance the Company's custom manufacturing and white label services with the added ability to assess the palatability of bespoke cannabis blends formulated with Valens' extensive terpene database. It will also expand the Company's innovation pipeline across all key product divisions.

Jeff Fallows, President of The Valens Company, added, "Cannabis research derived from human trials is highly critical and valuable at this stage of the industry's growth cycle, and we look forward to having data-backed knowledge of how consumers experience different products to advance our research and development strategy, and in turn, bring consumer focused products to market. This research licence not only solidifies our position as a one-stop shop for our customers by increasing our presence within their value chains, but also provides added credibility to our platform as we look to expand to new markets."

Loop Insights Inc. (TSXV: MTRX), a provider of contactless solutions and artificial intelligence ("AI") to drive real-time insights, automated marketing, and contact tracing to the brick and mortar space, announced the signing of a Pilot Agreement with Sunflora Inc., to implement Loop's analytics platform into 20 of its Your CBD Store retail locations.

Your CBD Store is the largest CBD brick and mortar retailer in the United States, selling award-winning SunMed products. Upon successful completion of the Pilot, it is the intention of both parties to implement Loop's artificial intelligence driven analytics platform across all 550+ Your CBD Store locations in 41 States across America.

Sunflora President of Franchise Systems, Jay Benge stated "There's no greater time to utilize top-tier artificial intelligence technology to gain an edge in this industry. Our customer base is huge, and it's important to understand their needs and preferences to maximize basket size, loyalty and wallet share. We look forward to working with Loop and building unparalleled experiences for our customers."

On August 10th, Loop announced a "Reseller Partnership And First Sale With Vend, A Global POS Company Used In 25,000 Stores Across 140 Countries". In that announcement Loop and Vend announced the first sale to a Vend client with 30 stores across North America.

Today's announcement represents the second deal through Vend in just 10 days, which bodes well for the future of the partnership and further demonstrates the efficacy of the Company's artificial intelligence driven marketing solution to the brick and mortar space.

Loop Insights CEO, Rob Anson stated "Our Vend partnership has already demonstrated great value for Loop by rapidly accelerating our entry into large verticals such as CBD retail. CBD sales are seeing massive growth rates since the start of the pandemic, so this Pilot with Sunflora Inc. puts Loop in a very strong position to become a partner to the massive CBD retail market."

TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, reported financial results for its second quarter ending June 30, 2020.

Some of the Second Quarter 2020 Financial Highlights included:

  • Net sales increased 169% to $47.2 million from $17.6 million.
  • Gross margin increased to 56%, compared to 9% (before gain on fair value of biological assets).
  • Adjusted EBITDA1 was $11.4 million, or 24% of net sales.
  • Positive Cashflow from operations of $10.4 million.
  • Cash & equivalents (including restricted cash) of $75 million, compared to $17 million.

"We are producing strong revenue growth while maintaining our focus on delivering industry leading margins and profitability," said Jason Ackerman, CEO and Executive Chairman of TerrAscend. "I am incredibly proud of the performance we have achieved to date and want to thank our entire team for the great execution. After achieving our first quarter of positive EBITDA in Q1, we have now achieved another significant milestone of positive cashflow from operations in Q2. Moving into the second half of 2020, we look forward to continued strong revenue and profitable growth as we bring our high-quality products to New Jersey patients through our first Apothecarium dispensary in the state, further expand our cultivation capacity in Pennsylvania, and add to our retail footprint in California. We are also very excited to complete the buildout of our cultivation facility in New Jersey which will begin to generate material sales in early 2021".

Namaste Technologies Inc. (TSXV: N) (OTC: NXTTF), a leading online platform for cannabis products, accessories, and responsible education, announced that its wholly-owned subsidiary, CannMart Inc., has signed an agreement with Indiva Inc., a wholly-owned subsidiary of Indiva Limited (TSXV:NDVA) (OTCQX:NDVAF), a leading Canadian producer of cannabis edibles and other cannabis products, to offer a selection of Indiva's products on CannMart's B2C distribution channel for their medical customers.

"CannMart is increasing its reach into the legal Canadian cannabis market and is a natural choice for our award winning products," said Niel Marotta, President and CEO, Indiva Limited. "Our softgels and capsules are highly regarded for their consistency and quality and will be available on the CannMart marketplace in late August. Later this fall we look forward to introducing our award-winning Bhang® Chocolate and Wana™ Sour Gummies to the CannMart product universe."

"Indiva's CBD Softgels, Indica Capsules along with Bhang® Chocolates and Wana™ Sour Gummies are a great addition to CannMart," said Meni Morim, CEO of Namaste

Indiva is a licensed producer of premium cannabis and cannabis products, and a provider of production and manufacturing services to third parties. Its state-of-the-art facility in London, Ontario includes environmentally-conscious grow rooms and a production and manufacturing space that produces safe, high-quality cannabis products. Indiva produces and distributes high-quality and award-winning Bhang® Chocolate, Wana™ Sour Gummies, Ruby® Cannabis Sugar, Sapphire™ Cannabis Salt, and other derivative products through license agreements and joint ventures.

Namaste is adding Indiva's product line to CannMart, its online marketplace, as it continues to expand its Cannabis 2.0 product offering. CannMart is an online marketplace carrying a large selection of legal cannabis products and accessories from many of the best cannabis producers in Canada and around the world. It is focused on providing medical cannabis patients and adult-use enthusiasts with access to the highest quality cannabis products available. CannMart also prepares, packages and distributes cannabis products through strategic relationships with leading government agencies.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

Hear Investor ideas cannabis potcast on iTunes

Hear the investor ideas potcast on Spotify

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Follow us on Cannabis Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/investorideas_potcast/

Download our Mobile App for iPhone and Android

Contact Investorideas.com

800-665-0411


Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories

Buy a cannabis guest post on Investorideas.com